Synthesis, reactivity and applications of 3,5-dimethyl-4-nitroisoxazole derivatives

3,5-dimethyl-4-nitroisoxazole derivatives are useful synthetic intermediates as the isoxazole nucleus chemically behaves as an ester, but establish better-defined interactions with chiral catalysts and lability of its N-O aromatic bond can unveil other groups such as 1,3-dicarbonyl compounds or carboxylic acids. In the present work, these features are employed in a 3,5-dimethyl-4-nitroisoxazole based synthesis of the γ-amino acid pregabalin, a medication for the treatment of epilepsy and neuropatic pain, in which this moiety is fundamental for the enantioselective formation of a chiral center by interaction with doubly-quaternized cinchona phase-transfer catalysts, whose ability of asymmetric induction will be investigated. Influence of this group in cinchona-derivatives catalysed stereoselective addition and Darzens reaction of a mono-chlorinated 3,5-dimethyl-4-nitroisoxazole and benzaldehyde will also be investigated.

Computer assisted synthesis and in-vitro cytotoxic evaluation of new pyrazole-fused isoquinolinoquinones derivatives as PI3K receptor antagonist with promising antitumoral activity

The importance of pyrazole and isoquinoline-5,8-dione scaffolds in medical chemistry is underlined by the high number of drugs currently on trading that contains these active ingredients. Due to their cytotoxic capability, the interest of medicinal chemists in these heterocyclic rings has grown exponentially especially, for cancer therapy. In this project, the first synthesis of pyrazole-fused isoquinoline-5,8-diones has been developed. 1,3-Dipolar cycloaddition followed by oxidative aromatization, established by our research group, has been employed. Screening of reaction conditions and characterization studies about the regioselectivity have been successfully performed. A remote control of regioselectivity, to achieve the two possible regioisomers has been accomplished. Through Molecular Docking studies, Structure-Activity relationship of differently substituted scaffolds containing our central core proved that a family of PI3K inhibitors have been discovered. Finally, in order to verify the promising antitumor activity, a first test of cell viability in vitro on T98G cell line of a solid brain tumor, the Glioblastoma Multiforme, showed cytotoxic inhibition comparable to currently trade anticancer drugs.

Direct C–H silylation and borylation of biomass derivatives by iridium heterogeneous catalysts

Furfural and its derivatives represent renewable and readily available platforms for a wide range of chemicals. Much attention has been devoted to their functionalization over the last years. TM-catalysed C–H activation has emerged as a powerful tool for synthesizing new C–C and C–X bonds. Moreover, it provides a sustainable way to obtain molecules by reducing waste and saving steps. At the same time, iridium catalysts have proven to be very active in some C–H functionalizations of several (hetero)arenes. Although very promising, this technique is still poorly applied on an industrial scale due to the severe conditions required. Continuous flow chemistry using heterogeneous catalysts appears to be a valuable way to overcome these problems. In this work, we present different solutions for the immobilization of homogeneous iridium complexes on silica gels, using bidentate amines and phosphines as anchoring ligands. We successfully employed the catalysts in C–H silylation and borylation of furfural, using C2 located directing group. In this way, we finally obtained a suitable catalyst that could be potentially applied in continuous-flow chemistry.